TransMedics Group, Inc. (TMDX) › Operating IncomeTransMedics Group, Inc. (TMDX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$20.24M2019: -$29.60M2020: -$26.38M2021: -$39.43M2022: -$31.44M2023: -$28.73M2024: $37.50M2025: $108.58M$108.58M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$108.58M+189.6%2024$37.50M+230.5%2023-$28.73M+8.6%2022-$31.44M+20.3%2021-$39.43M-49.4%2020-$26.38M+10.9%2019-$29.60M-46.3%2018-$20.24M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share